Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:29:20 EDT Sat 17 May 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:MYGN - MYRIAD GENETICS INC - https://www.myriad.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MYGN - Q2.04.08·6.771.24.13+0.020.52,193.38,64910,0844.12  4.18  4.0529.30  3.811919:40:49May 1415 min RT 2¢

Recent Trades - Last 10 of 10084
Time ETExPriceChangeVolume
19:40:49Q4.10-0.011
19:01:30Q4.09-0.02100
18:54:25Q4.0999-0.01011
18:39:01Q4.09-0.025
18:37:16Q4.10-0.01250
18:22:20Q4.10-0.0120
17:54:11Q4.150.04368
17:32:39Q4.10-0.01200
17:23:52Q4.10-0.01170
17:19:06Q4.11 23

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-14 16:45U:MYGNNews ReleaseUpdated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
2025-05-07 16:30U:MYGNNews ReleaseMyriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
2025-05-06 16:05U:MYGNNews ReleaseMyriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
2025-04-30 08:00U:MYGNNews ReleaseConcerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor
2025-04-29 09:00U:MYGNNews ReleaseMyriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
2025-04-25 16:05U:MYGNNews ReleaseMyriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
2025-04-21 16:05U:MYGNNews ReleaseMyriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing
2025-04-08 16:15U:MYGNNews ReleaseMyriad Genetics Announces Inducement Awards
2025-04-07 08:00U:MYGNNews ReleaseMyriad Genetics Names Brian Donnelly as New Chief Commercial Officer
2025-02-27 16:15U:MYGNNews ReleaseMyriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
2025-02-24 16:05U:MYGNNews ReleaseMyriad Genetics Announces Senior Leadership Transition
2025-02-24 16:05U:MYGNNews ReleaseMyriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth
2025-02-24 08:30U:MYGNNews ReleaseMyriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
2025-02-19 08:30U:MYGNNews ReleaseMyriad Genetics Included in Forbes America's Best Employers 2025 List
2025-02-18 08:30U:MYGNNews ReleaseMyriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
2025-02-06 08:30U:MYGNNews ReleaseMyriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test
2025-02-05 16:15U:MYGNNews ReleaseMyriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay
2025-02-05 08:30U:MYGNNews ReleaseMyriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration
2025-01-29 08:30U:MYGNNews ReleaseMyriad Genetics Unveils Groundbreaking Eight Weeks' Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference
2025-01-23 08:30U:MYGNNews ReleaseMyriad Genetics Introduces Online Prenatal Genetic Testing Resource